We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Centrifugal Speed Affects Light Transmission Aggregometry

By LabMedica International staff writers
Posted on 02 Jan 2012
Light transmission aggregometry (LTA) is considered the gold standard for investigating platelet activity ex vivo, but LTA protocols are not standardized.

Centrifugation speed is an essential component of platelet preparation in LTA and has yet to be standardized, which may affect platelet aggregation leading to a potential source of variance in results. More...


In a study, conducted at the New York University School of Medicine (NY, USA) the effect of relative centrifugal force (RCF) intensity on LTA results was investigated. Ten healthy controls had venous blood drawn and centrifuged at 150, 200, 300, and 500 × g for 10 minutes. Cell counts in whole blood and platelet-rich plasma (PRP) were measured using a hematology analyzer. LTA was performed using 1.0 µM adenosine diphosphate (ADP) and 0.4 µM epinephrine as an agonist. The percentage of aggregation was compared at 60, 120, 180, and 300 seconds and at maximum aggregation.

Centrifugation speed was associated with a statistically significant decrease in platelet counts and decrease in mean platelet volume in PRP. Consistently, platelet aggregation in response to 0.4 µM of epinephrine decreased significantly with increasing centrifuge RCF at 60, 120, 180, 300 seconds and at maximum aggregation. Whole blood and PRP cell blood count were performed using a Sysmex XE-2100 analyzer (Mundelein, IL, USA). LTA was performed using the AggRAM light transmission aggregometer, reagents, cuvettes, and stir bars (Helena Laboratories, Beaumont, TX, USA).

The authors concluded that using different centrifuge RCF results in changes in PRP properties and LTA. This difference in methodology gives pause to comparing LTA from studies with different protocols and may help explain some of the inconsistencies observed in the field. Consequently, consideration should be given to standardize centrifugation parameters in performing LTA. The study is planned to appear in the February 2012 print edition of the International Journal of Laboratory Hematology.

Related Links:
New York University School of Medicine
Sysmex
Helena Laboratories



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.